Suchergebnisse - "Corso, Alessandro"

PubPharm (60)

1

Incidence and clinical progression of asymptomatic peripherally inserted central catheter-related thrombosis in solid neoplasm patients : ultrasound insights from a prospective cohort study

enthalten in: Research and practice in thrombosis and haemostasis | 2024

von Cominacini, M. | De Marchi, S. | Tosi, F. | +5

2

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies : A report from the ITA-HEMA-COV

enthalten in: Hematological oncology | 2022

von Zappasodi, P. | Cattaneo, C. | Valeria Ferretti, V. | +52

3

Management of infectious risk of daratumumab therapy in multiple myeloma : A consensus-based position paper from an ad hoc Italian expert panel

enthalten in: Critical reviews in oncology/hematology | 2022

von Girmenia, C. | Cavo, M. | Corso, A. | +6

4

Experts' consensus on the definition and management of high risk multiple myeloma

enthalten in: Frontiers in oncology | 2022

von Marcon, C. | Simeon, V. | Deias, P. | +10

5

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma : A subanalysis of OPTIMISMM by clinical characteristics

enthalten in: European journal of haematology | 2022

von Richardson, P. | Schjesvold, F. | Weisel, K. | +25

6

A prognostic model for patients with lymphoma and COVID-19 : a multicentre cohort study

enthalten in: Blood advances | 2022

von Visco, C. | Marcheselli, L. | Mina, R. | +55

ErratumIn: Blood Adv. 2023 Mar 28;7(6):1065. - PMID 36943316

7

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies

enthalten in: British journal of haematology | 2021

von Passamonti, F. | Romano, A. | Salvini, M. | +52

8

Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma : Results of an Early Access Treatment Protocol in Europe and Russia

enthalten in: Oncology and therapy | 2021

von Cook, G. | Corso, A. | Streetly, M. | +11

9

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM) : outcomes by prior treatment at first relapse

enthalten in: Leukemia | 2021

von Dimopoulos, M. | Weisel, K. | Moreau, P. | +17

10

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy : a retrospective, multicentre, cohort study

enthalten in: The Lancet. Haematology | 2020

von Passamonti, F. | Cattaneo, C. | Arcaini, L. | +72

CommentIn: Lancet Haematol. 2020 Oct;7(10):e701-e703. - PMID 32798474

1
2
3
4
5
6
Nächster »
[6]